Small-Molecule Inhibition of BRDT for Male Contraception
Open Access
- 17 August 2012
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 150 (4), 673-684
- https://doi.org/10.1016/j.cell.2012.06.045
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic backgroundDevelopmental Biology, 2011
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences of the United States of America, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Recent developments in the MAFFT multiple sequence alignment programBriefings in Bioinformatics, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- GenePattern 2.0Nature Genetics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005